Shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA – Get Free Report) have earned an average rating of “Moderate Buy” from the seven ratings firms that are currently covering the stock, MarketBeat Ratings reports. Three research analysts have rated the stock with a hold recommendation, three have assigned a buy recommendation and one has assigned a strong buy recommendation to the company. The average 1-year price target among analysts that have covered the stock in the last year is $20.00.
SBRA has been the topic of a number of recent research reports. Scotiabank increased their price objective on shares of Sabra Healthcare REIT from $19.00 to $20.00 and gave the company a “sector perform” rating in a research note on Monday, June 23rd. JMP Securities increased their price objective on shares of Sabra Healthcare REIT from $20.00 to $22.00 and gave the company a “market outperform” rating in a research note on Wednesday, August 6th.
View Our Latest Stock Report on Sabra Healthcare REIT
Sabra Healthcare REIT Price Performance
Sabra Healthcare REIT (NASDAQ:SBRA – Get Free Report) last released its quarterly earnings data on Monday, August 4th. The real estate investment trust reported $0.38 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.36 by $0.02. Sabra Healthcare REIT had a net margin of 24.87% and a return on equity of 6.69%. The firm had revenue of $189.15 million for the quarter, compared to the consensus estimate of $185.64 million. During the same period last year, the firm earned $0.36 earnings per share. The company’s quarterly revenue was up 7.4% on a year-over-year basis. Sabra Healthcare REIT has set its FY 2025 guidance at 1.450-1.470 EPS. Sell-side analysts forecast that Sabra Healthcare REIT will post 1.45 EPS for the current fiscal year.
Sabra Healthcare REIT Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Friday, August 29th. Shareholders of record on Friday, August 15th will be paid a $0.30 dividend. This represents a $1.20 annualized dividend and a yield of 6.2%. The ex-dividend date is Friday, August 15th. Sabra Healthcare REIT’s dividend payout ratio (DPR) is 157.89%.
Institutional Investors Weigh In On Sabra Healthcare REIT
Institutional investors have recently bought and sold shares of the company. SVB Wealth LLC acquired a new stake in Sabra Healthcare REIT in the first quarter valued at approximately $34,000. UMB Bank n.a. boosted its stake in Sabra Healthcare REIT by 379.6% in the first quarter. UMB Bank n.a. now owns 2,048 shares of the real estate investment trust’s stock valued at $36,000 after acquiring an additional 1,621 shares in the last quarter. Wealth Preservation Advisors LLC acquired a new stake in Sabra Healthcare REIT in the first quarter valued at approximately $38,000. EverSource Wealth Advisors LLC boosted its stake in Sabra Healthcare REIT by 150.7% in the second quarter. EverSource Wealth Advisors LLC now owns 2,555 shares of the real estate investment trust’s stock valued at $47,000 after acquiring an additional 1,536 shares in the last quarter. Finally, Northwestern Mutual Wealth Management Co. boosted its stake in Sabra Healthcare REIT by 61.2% in the first quarter. Northwestern Mutual Wealth Management Co. now owns 2,806 shares of the real estate investment trust’s stock valued at $49,000 after acquiring an additional 1,065 shares in the last quarter. 99.40% of the stock is currently owned by institutional investors and hedge funds.
About Sabra Healthcare REIT
Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.
Featured Articles
- Five stocks we like better than Sabra Healthcare REIT
- Why Are These Companies Considered Blue Chips?
- Lowe’s Builds Value for Investors: Still a Good Buy in 2025
- What is the Dow Jones Industrial Average (DJIA)?
- Jackson Hole 2025: Fed’s Signal Could Shift Stocks Fast
- Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance
- Rocket Lab Stock: Breakout Brewing or Time for Patience?
Receive News & Ratings for Sabra Healthcare REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Healthcare REIT and related companies with MarketBeat.com's FREE daily email newsletter.